Effect of Local Fibrinogen Administration on Postoperative Bleeding in Open Prostatectomy Surgery.

Anesth Pain Med 2018 Jun 29;8(3):e73983. Epub 2018 Jun 29.

Department of Anesthesia, Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Background: Open prostatectomy is still accompanied by some postoperative bleeding. Prescribing fibrinogen to promote clot formation in patients with bleeding is of critical importance. This research studied the effects of local injection of fibrinogen on level of postoperative bleeding in open prostatectomy.

Methods: Overall, 44 patients were randomly entered in a study on open prostatectomy. Patients in the intervention group received local injections of 500 mg fibrinogen (20 mL) dissolved in distilled water, and the control group patients only received 20 mL of normal saline, where the injections were given by the surgeon at the prostatectomy operation site. All patients were tested for hemoglobin, hematocrit, PT, PTT, INR, and fibrinogen level. Also, the amount of blood loss and requirement for blood products were recorded.

Results: The study groups showed no difference regarding baseline variables. One patient in the fibrinogen group (1.66%) and four patients in the control group (6.66%) received blood products (P < 0.05), and the blood drainage tube at 24 hours after operation was 36.50) 18.70 (mL in the fibrinogen group and 151.36) 120.58 (mL in the control group (P = 0.005). There were no differences in hemoglobin, hematocrit, PT, PTT, INR, and serum fibrinogen level between the groups at any time.

Conclusions: The current study demonstrated that using fibrinogen in patients with high bleeding risk may effectively reduce the amount of bleeding and its subsequent blood transfusion requirement, after open prostatectomy surgery.

Download full-text PDF

Source
http://anesthpain.com/en/articles/73983.html
Publisher Site
http://dx.doi.org/10.5812/aapm.73983DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119345PMC
June 2018

Publication Analysis

Top Keywords

open prostatectomy
16
control group
12
fibrinogen level
12
postoperative bleeding
12
prostatectomy surgery
8
hemoglobin hematocrit
8
ptt inr
8
fibrinogen group
8
blood products
8
hematocrit ptt
8
fibrinogen
8
bleeding open
8
patients
7
group
6
bleeding
6
blood
5
open
5
prostatectomy
5
groups difference
4
variables patient
4

Similar Publications

The Effect of Fibrinogen on Blood Loss After Lumbar Surgery: A Double-Blind Randomized Clinical Trial.

Anesth Pain Med 2019 Jun 1;9(3):e91199. Epub 2019 Jun 1.

Department of Anesthesia, Ahvaz Anesthesiology and Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Background: Spinal surgeries often have a high risk of hemorrhage during and after surgery, thus most patients require blood transfusions and blood products. Fibrinogen is used in different forms to control hemorrhage.

Objectives: The present study aimed to evaluate the outcomes of prophylactic fibrinogen administration in reducing hemorrhage after lumbar surgery. Read More

View Article and Full-Text PDF
June 2019

Local Administration of Tranexamic Acid During Prostatectomy Surgery: Effects on Reducing the Amount of Bleeding.

Nephrourol Mon 2016 Nov 23;8(6):e40409. Epub 2016 Aug 23.

Department of Anesthesiology, Tehran University of Medical Sciences, Tehran, IR Iran.

Background: One of the issues in prostatectomy surgery is bleeding. Although tranexamic acid (TRA) is an antifibrinolytic agent for reducing bleeding, controversies surround its use.

Objectives: In this study, the effect of local administration of TRA on reducing bleeding during prostatectomy surgery was evaluated. Read More

View Article and Full-Text PDF
November 2016

The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial.

Anesth Pain Med 2015 Feb 1;5(1):e22846. Epub 2015 Feb 1.

Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Background: Postoperative bleeding after cardiac reoperations is among the most complicating problems, both for the physicians and for the patients. Many modalities have been used to decrease its adverse effects and the need for blood products administration.

Objectives: In a randomized double-blinded clinical trial of redo cardiac valve surgery in adult, the effect of active recombinant factor VII (rFVIIa) on postoperative bleeding was compared with placebo. Read More

View Article and Full-Text PDF
February 2015

Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial.

Anesth Pain Med 2019 Aug 27;9(4):e92165. Epub 2019 Aug 27.

Department of Anesthesia, Ahvaz Anesthesiology and Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Background: Prevention and optimal treatment of postoperative bleeding are of great clinical importance in various types of surgeries including coronary artery bypass graft (CABG). Reducing the amount of bleeding will reduce the complications subsequent to blood transfusion. The positive effects of coagulation factors, especially fibrinogen, after cardiovascular bypass could have beneficial effects due to reduced bleeding and less need for blood transfusion. Read More

View Article and Full-Text PDF
August 2019